Sustained activation of MAPK/ERKs signaling pathway in cystic kidneys from bcl-2 -/- mice

Christine M Sorenson1, Nader Sheibani

  • 1Department of Pediatrics, University of Wisconsin-Madison, Madison, Wisconsin 53792, USA. cmsorenson@facstaff.wisc.edu

Insights

Aberrant kidney development involves focal adhesion kinase (FAK) signaling. In B cell lymphoma/leukemia-2 (bcl-2) knockout mice, sustained MAPK/ERK activation via Src/FAK contributes to renal cyst hyperproliferation.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Cell Signaling

Background:

  • Nephrogenesis involves regulated cell proliferation, survival, and differentiation.
  • Aberrant signaling pathways, including focal adhesion kinase (FAK), are implicated in renal cyst formation.
  • Previous studies showed sustained FAK and paxillin phosphorylation in cystic kidneys of B cell lymphoma/leukemia-2 (bcl-2) knockout mice.

Purpose of the Study:

  • To investigate the downstream signaling pathways affected by FAK in the context of cystic kidneys.
  • To determine the role of FAK-mediated signaling in the hyperproliferation observed in bcl-2 knockout mouse kidneys.

Main Methods:

  • Analysis of protein phosphorylation and expression levels in kidney tissues from postnatal day 20 bcl-2 +/+ and bcl-2 -/- mice.
  • Western blotting was used to assess the activation status of key signaling molecules, including Src, MAPK/ERK, c-Jun NH2-terminal kinase, phosphatidylinositol-3-kinase, protein kinase B, and Shc proteins.

Main Results:

  • Cystic kidneys from bcl-2 -/- mice exhibited sustained phosphorylation of Src and mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK).
  • Phosphorylation levels of c-Jun NH2-terminal kinase, phosphatidylinositol-3-kinase, and protein kinase B were similar in normal and cystic kidneys.
  • Expression of Shc adapter proteins (p66Shc, p52/p46Shc) was comparable between normal and cystic kidneys, with p52/p46Shc constitutively expressed during nephrogenesis.

Conclusions:

  • Sustained activation of the MAPK/ERK pathway, potentially through the Src/FAK signaling cascade, may drive the observed hyperproliferation in cystic kidneys of bcl-2 -/- mice.
  • These findings highlight the critical role of FAK-mediated signaling in regulating cell proliferation during kidney development and disease.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...